Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
NCT01681446
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
296
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
interferon-alpha (IFN-alpha)
Sponsor
Fudan University